Rhythm Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.About RYTM
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with rare diseases. The firm offers IMCIVREE (setmelanotide), a precision medicine designed to treat hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases.
RYTM Key Statistics
Stock Snapshot
The current Rhythm Pharmaceuticals(RYTM) stock price is $79.43, with a market capitalization of 5.42B. The stock trades at a price-to-earnings (P/E) ratio of -26.35.
During the trading session on 2026-03-27, Rhythm Pharmaceuticals(RYTM) shares reached a daily high of $83.65 and a low of $78.91. At a current price of $79.43, the stock is +0.7% higher than the low and still -5.1% under the high.
Trading activity shows a volume of 87.72K, compared to an average daily volume of 1.26M.
The stock's 52-week range extends from a low of $45.91 to a high of $122.20.
The stock's 52-week range extends from a low of $45.91 to a high of $122.20.
RYTM News
Rhythm Pharmaceuticals ( (RYTM) ) has provided an announcement. On March 26, 2026, Rhythm Pharmaceuticals reported that the EMA’s Committee for Medicinal Produ...
Rhythm Pharmaceuticals (RYTM) is back in focus after the FDA approved a broader label for IMCIVREE to treat acquired hypothalamic obesity in patients aged 4 and...
Analyst ratings
94%
of 17 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.